LPP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.610000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.037600E-01
Normal-vs-Stage2
6.912200E-01
Normal-vs-Stage3
2.363800E-01
Normal-vs-Stage4
2.541800E-01
Stage1-vs-Stage2
9.662200E-01
Stage1-vs-Stage3
1.647410E-01
Stage1-vs-Stage4
2.047800E-01
Stage2-vs-Stage3
1.818700E-03
Stage2-vs-Stage4
2.770200E-01
Stage3-vs-Stage4
1.382030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.998600E-01
Normal-vs-AfricanAmerican
4.737800E-01
Normal-vs-Asian
8.153800E-01
Caucasian-vs-AfricanAmerican
5.045200E-01
Caucasian-vs-Asian
9.823200E-01
AfricanAmerican-vs-Asian
6.006800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.995600E-01
Normal-vs-Female
7.200000E-01
Male-vs-Female
5.097400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.661800E-01
Normal-vs-Age(41-60Yrs)
5.573400E-01
Normal-vs-Age(61-80Yrs)
8.284000E-01
Normal-vs-Age(81-100Yrs)
8.895600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.735400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.665000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.139000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.884370E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.832370E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.200600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.013600E-01
Normal-vs-Daily Drinker
7.574600E-01
Normal-vs-Weekly Drinker
7.955800E-01
Normal-vs-Occasional Drinker
6.341200E-01
Normal-vs-Social Drinker
5.989400E-01
Non Drinker-vs-Daily Drinker
5.676600E-01
Non Drinker-vs-Weekly Drinker
4.929000E-01
Non Drinker-vs-Occasional Drinker
2.092600E-01
Non Drinker-vs-Social Drinker
2.117400E-01
Daily Drinker-vs-Weekly Drinker
3.105400E-01
Daily Drinker-vs-Occasional Drinker
1.267170E-01
Daily Drinker-vs-Social Drinker
1.514760E-01
Weekly Drinker-vs-Occasional Drinker
6.640000E-01
Weekly Drinker-vs-Social Drinker
5.083800E-01
Occasional Drinker-vs-Social Drinker
7.452800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.941400E-01
Normal-vs-Grade 2
8.737900E-02
Normal-vs-Grade 3
8.026100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.561650E-01
Grade 1-vs-Grade 3
1.596820E-01
Grade 1-vs-Grade 4
2.941400E-01
Grade 2-vs-Grade 3
8.096200E-01
Grade 2-vs-Grade 4
8.737900E-02
Grade 3-vs-Grade 4
8.026100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.373000E-01
Normal-vs-NonDiabetic
9.026200E-01
Diabetic-vs-NonDiabetic
6.986600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.464000E-01
Normal-vs-NoPancreatitis
8.956400E-01
Pancreatitis-vs-NoPancreatitis
4.297800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.692400E-01
Normal-vs-N1
7.053400E-01
N0-vs-N1
5.093400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.771000E-01
Normal-vs-TP53-NonMutant
8.504200E-01
TP53-Mutant-vs-TP53-NonMutant
1.200800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
